Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis.
Saved in:
| Title: | Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis. |
|---|---|
| Authors: | Foong YC; University of Tasmania Menzies Institute for Medical Research, Hobart, Tasmania, Australia.; Neurology, Royal Hobart Hospital, Hobart, Tasmania, Australia., Merlo D; Department of Neuroscience, Monash University, Clayton, Victoria, Australia., Gresle M; Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.; Melbourne Brain Centre, Parkville, Victoria, Australia., Buzzard K; Department of Neurology, Box Hill Hospital, Box Hill, Victoria, Australia., Horakova D; Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Havrdova EK; Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Kalincik T; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.; Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia., Roos I; Clinical Outcomes Research Unit, The University of Melbourne, Department of Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia., Hodgkinson S; Departments of Nephrology and Neurology, Liverpool Hospital, Chipping Norton, New South Wales, Australia.; Liverpool Hospital, Liverpool, New South Wales, Australia., Lechner-Scott J; The University of Newcastle, Newcastle, New South Wales, Australia., Lugaresi A; UOSI Riabilitazione Sclerosi Multipla, IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy.; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy., Weinstock-Guttman B; Neurology, Jacobs Comprehensive MS Treatment and Research Center, Buffalo, New York, USA., Ozakbas S; Dokuz Eylul University, İzmir, Turkey., Surcinelli A; Department of Neuroscience, S Maria delle Croci Hospital, Ravenna, Italy., Foschi M; Neurology Unit, Ospedale S.Maria delle Croci, AUSL Romagna, Ravenna, Italy., Boz C; Karadeniz Technical University, Trabzon, Turkey., Khoury SJ; Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.; American University of Beirut, Beirut, Lebanon., Yamout B; Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.; Neurology Department, American University of Beirut, Beirut, Lebanon., Laureys G; Universitair Ziekenhuis Gent, Gent, Belgium., Blanco Y; Hospital Clinic and Institut d'Investigació Biomèdica August Pi I Sunyer (IDIBAPS), Center for Neuroimmunology, Service of Neurology Barcelona, ES, Barcelona, Spain., Skibina O; Neurosciences, The Alfred, Melbourne, Victoria, Australia., Kuhle J; Neurology, University Hospital Basel, Basel, Switzerland., John N; Department of Medicine, Monash University, Clayton, Victoria, Australia.; Department of Neurology, Monash Health, Clayton, Victoria, Australia., Alroughani R; Amiri Hospital, Kuwait City, Kuwait., Prevost J; Centre integre de sante et de services sociaux des Laurentides point de service de Saint-Jerome, Saint-Jerome, Québec, Canada., Van Pesch V; Neurology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Tomassini V; Istituto di Tecnologie Avanzate Biomediche (ITAB), Dipartimento di Neuroscienze e Imaging e Scienze Cliniche; Centro Sclerosi Multipla, Clinica Neurologica, Ospedale SS Annunziata, Università degli Studi Gabriele d'Annunzio Chieti Pescara, Chieti, Italy.; Division of Psychological Medicine and Clinical Neurosciences, University Hospital of Wales; Helen Durham Centre for Neuroinflammation, Cardiff University School of Medicine, Cardiff, UK., Prat A; Hôpital Notre Dame, CHUM and Universite de Montreal, Montreal, Québec, Canada., Girard M; Hopital Notre Dame, Montreal, Québec, Canada., Terzi M; Ondokuz Mayis Üniversitesi, Samsun, Turkey., Shaygannejad V; Neurology, Isfahan University of Medical Sciences, Isfahan, The Islamic Republic of Iran., Ampapa R; Nemocnice Jihlava, Jihlava, Czech Republic., Gray O; Department of Neurology, Craigavon Area Hospital, Portadown, UK., Etemadifar M; Isfahan Multiple Sclerosis Society, Isfahan, The Islamic Republic of Iran., Guimarães J; Neurology Department, Hospital de São João, Porto, Portugal., McCombe PA; UQCCR, The University of Queensland, Brisbane, Queensland, Australia., Gerlach O; Department of Neurology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands, Sittard-Geleen, Netherlands., Solaro C; Department of Head and Neck Neurology, ASL3 Genovese, Genova, Italy., Butzkueven H; Department of Neuroscience, Monash University Central Clinical School, Melbourne, Victoria, Australia., Zhu C; Monash University, Melbourne, Victoria, Australia., van der Walt A; Monash University Central Clinical School, Melbourne, Victoria, Australia anneke.vanderwalt@monash.edu.; Alfred Hospital, Melbourne, Victoria, Australia., Study Group M; The Alfred, Melbourne, Québec, Australia. |
| Source: | Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2025 Dec 12; Vol. 97 (1), pp. 50-58. Date of Electronic Publication: 2025 Dec 12. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 2985191R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-330X (Electronic) Linking ISSN: 00223050 NLM ISO Abbreviation: J Neurol Neurosurg Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
